Efficacy of photodynamic therapy with methyl aminolevulinate in the treatment of superficial and nodular basal cell carcinoma: An open-label trial

European Journal of Dermatology

Volumn 17, Issue 5, 2007, Pages 412-415

  Surrenti, Tiziana ^a   De Angelis, Linda ^a   Di Cesare, Antonella ^a   Fargnoli, Maria Concetta ^a   Peris, Ketty ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Methyl aminolevulinate; Nodular basal cell carcinoma; Photodynamic therapy; Superficial basal cell carcinoma

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; BURNING SENSATION; CONTROLLED STUDY; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; ERYTHEMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN; PHOTODYNAMIC THERAPY;

ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; CARCINOMA, BASAL CELL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 34548800301     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: 10.1684/ejd.2007.0239     Document Type: Article

References (17)

1. Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol 2002; 146: 1-6; (S61).
2. Thissen MR, Neumann MH, Schouten LJ. A systematic review of treatment modalities for primary basal cell carcinomas. Arch Dermatol 1999; 135: 1177-83.
3. Nagore E, Grau C, Molinero J, Fortea JM. Positive margins in basal cell carcinoma: relationship to clinical features and recurrence risk. A retrospective study of 248 patients. J Eur Acad Dermatol Venereol 2003; 17: 167-70.
4. Ceilley RI, Del Rosso JQ. Current modalities and new advances in the treatment of basal cell carcinoma. Int J Dermatol 2006; 45: 489-98.
5. Morton CA, Whitehurst C, McColl JH, Moore JV, MacKie RM. Photodynamic therapy for large or multiple patches of Bowen's disease and basal cell carcinoma. Arch Dermatol 2001; 137: 319-24.
6. Calzavara-Pinton PG. Repetitive photodynamic therapy with topical delta-aminolevulinic acid as an appropriate approach to the routine treatment of superficial nonmelanoma skin tumours. J Photochem Photobiol B 1995; 29: 53-7.
7. Peng Q, Soler AM, Warloe T, Nesland JM, Giercksky KE. Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate. J Photochem Photobiol 2001; 62: 140-5.
8. Kalka K, Merk H, Mukhtar H. Photodynamic therapy in dermatology. J Am Acad Dermatol 2000; 42: 389-413.
9. Rhodes LE, De Rie M, Enstrom Y, Groves R, Morken T, Goulden V, Wong GAE, Grob JJ, Varma S, Wolf P. Photodynamic therapy using topical methyl aminolevulinate versus surgery for nodular basal cell carcinoma. Arch Dermatol 2004; 140: 17-23.
10. Soler AM, Warloe T, Berner A, Giercksky KE. A follow up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinoma treated with methyl 5-aminolevulinate-based photodynamic therapy alone and with prior curettage. Br J Dermatol 2001; 145: 467-71.
11. Foley P. Clinical efficacy of methyl aminolevulinate (metvix) photodynamic therapy. J Dermatol Treat 2003; 14(S3): 15-22.
12. Horn M, Wolf P, Wulf HC, Warloe T, Fritsch C, Rhodes LE, Kaufmann R, De Rie M, Legat FJ, Stender IM, Soler AM, Wennberg AM, Wong GAE, Larko O. Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. Br J Dermatol 2003; 149: 1242-9.
13. Vinciullo C, Elliott T, Francis D, Gebauer K, Spelman L, Nguyen R, Weightman W, Sheridan A, Reid C, Czamecki D, Murrel D. Photodynamic therapy with topical methyl aminolaevulinate for "difficult to treat" basal cell carcinoma. Br J Dermatol 2005; 152: 765-72.
14. Babilas P, Landthaler M, Szeimies RM. Photodynamic therapy in dermatology. Eur J Dermatol 2006; 16: 340-8.
15. Morton CA, Brown SB, Collins S, Ibbotson S, Jenkinson H, Kurwa H, Langmack K, McKenna K, Moseley H, Pearse AD, Stringer M, Taylor DK, Wong G, Rhodes LE. Guidelines for topical photodynamic therapy: report of a workshop of a British Photodermatology Group. Br J Dermatol 2002; 146: 552-67.
16. Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1988; 124: 869-71.
17. Menzies SW, Westerhoff K, Rabinovitz H, Kopf AW, McCarthy WH, Katz B. Surface microscopy of pigmented basal cell carcinoma. Arch Dermatol 2000; 136: 1012-6.